Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Pediatrics Medicine Market by Type (Short Term Illness and Chronic Illness) - Global Opportunity Analysis and Industry Forecast, 2020-2027
| A03432 | Pages: NA | Feb 2021 | 2971 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pediatrics Medicine Market
Request Now !Paediatrics medicines belong to the special category of medicines that are prescribed for the paediatrics group of patients, in different indications. These drugs are prescribed in different diseases such as anorexia, birth defects, asthma and others. Several acts such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatrics Research Equity Act (PREA) has been passed to increase the R&D investments on paediatric medicines. The drivers that drive the market growth are rise in prevalence of diseases such as diabetes and obesity in children along with awareness in people. In addition, rise in government funding and awareness programs also fuel the market growth. However, low disposable income and side effects such as headache along with anxiety restraints the market growth. Technological developments in the field of paediatrics medicine will prove as a future opportunity in the market growth.
The report segments the market on the basis of type and region. Based on type, the market can be segmented into short term illness such as ear infection, upper respiratory infections & others, and chronic illness such as cystic fibrosis, diabetes and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players of the market are Lupin, GlaxoSmithKline plc., Pfizer Inc., Sanofi S.A., F. Hoffman-La Roche Ltd, Abbott Laboratories, Heron Therapeutics Inc., Eli Lilly & Company, Novartis A.G, Merck Co.Ltd., and Cipla Inc.
Key Benefits
- The study provides an in-depth analysis of the global pediatrics medicine market along with the current trends and future estimations to elucidate the imminent investment pockets.
- Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry is provided for the period of 20162023 to assiststakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps in understanding the trends in types of pediatrics medicine across the globe.
- Key market players and their strategies have been provided to understand the competitive outlook of theindustry.
Pediatrics Medicine Market Key Segments:
By Type
- Short Term Illness
- Ear Infection
- Upper Respiratory Infections
- Others
- Chronic Illness
- Cystic Fibrosis
- Diabetes
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Argentina
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities
CHAPTER 4 GLOBAL PEDIATRICS MEDICINE MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SHORT TERM ILLNESS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Ear Infection
4.2.4.1. Market size and forecast
4.2.5. Upper Respiratory Infections
4.2.5.1. Market size and forecast
4.2.6. Others
4.2.6.1. Market size and forecast
4.3. CHRONIC ILLNESS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.2.4. Cystic Fibrosis
4.3.4.1. Market size and forecast
4.3.5. Diabetes
4.3.5.1. Market size and forecast
4.3.6. Others
4.3.6.1. Market size and forecast
CHAPTER 5 GLOBAL PEDIATRICS MEDICINE MARKET, BY REGION
5.1. OVERVIEW
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.2.4. North America Pediatric Medicine Market by Type
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.3.4. Europe Pediatrics Medicine Market by Type
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.3. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.3. China market size and forecast
5.4.3.3. Australia market size and forecast
5.4.3.4. India market size and forecast
5.4.3.7. Rest of Asia-Pacific market size and forecast
5.4.4. Asia-Pacific Pediatric Medicine Market by Type
5.5. LAMEA
5.5.1. Key market trends
5.5.3. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.3. Turkey market size and forecast
5.5.3.3. Argentina market size and forecast
5.5.3.4. South Africa market size and forecast
5.5.3.5. Rest of LAMEA market size and forecast
5.5.4. LAMEA Pediatric Medicine Market by Type
CHAPTER 6 COMPANY PROFILES
6.1. LUPIN
6.1.1. Operating business segments
6.1.3. Business performance
6.1.3. Key strategic moves and developments
6.3. GLAXOSMITHKLINE PLC
6.3.1. Operating business segments
6.3.3. Business performance
6.3.3. Key strategic moves and developments
6.3. PFIZER INC.
6.3.1. Operating business segments
6.3.3. Business performance
6.3.3. Key strategic moves and developments
6.4. SANOFI S.A.
6.4.1. Operating business segments
6.4.3. Business performance
6.4.3. Key strategic moves and developments
6.5. F.HOFFMAN-LA ROCHE LTD.
6.5.1. Operating business segments
6.5.3. Business performance
6.5.3. Key strategic moves and developments
6.6. ABBOTT LABORATORIES
6.6.1. Operating business segments
6.6.3. Business performance
6.6.3. Key strategic moves and developments
6.7. HERON THERAPEUTICS, INC.
6.7.1. Operating business segments
6.7.3. Business performance
6.7.3. Key strategic moves and developments
6.8. ELI LILLY AND COMPANY
6.8.1. Operating business segments
6.8.3. Business performance
6.8.3. Key strategic moves and developments
6.9. NOVARTIS A.G
6.9.1. Operating business segments
6.9.3. Business performance
6.9.3. Key strategic moves and developments
6.10. CIPLA INC.
6.10.1. Operating business segments
6.10.3. Business performance
6.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Pediatrics Medicine Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers